Literature DB >> 19951849

Expression of signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 in urothelial carcinoma.

Wan-Ting Huang1, Sheau-Fang Yang, Chun-Chieh Wu, Wan-Tzu Chen, Ya-Chun Huang, Yue-Chiu Su, Chee-Yin Chai.   

Abstract

In this study, we investigated the expression of phosphorylated signal transducer and activator of transcription 3 (p-STAT3) Tyr705 and suppressor of cytokine signaling 3 (SOCS3) in urothelial carcinoma (UC). p-STAT3 (Tyr705) and SOCS3 were analyzed by immunohistochemistry using tissue microarray and Western blotting. Our results showed that p-STAT3 (Tyr705) was frequently detected in high-grade and infiltrating UC. However, there was no difference in p-STAT3 (Tyr705) staining between UC of the upper and lower urinary tracts. In addition, there was no significant correlation between expression of SOCS3 and histological differentiation and invasiveness of UC. These findings suggest that overexpression of p-STAT3 (Tyr705) occurs in UC, and that pathways other than SOCS3 may contribute to its activation in this cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951849     DOI: 10.1016/S1607-551X(09)70569-8

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  9 in total

1.  Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma.

Authors:  Wen-Yong Wu; Jun Li; Zheng-Sheng Wu; Chang-LE Zhang; Xiang-Ling Meng; Peter E Lobie
Journal:  Exp Ther Med       Date:  2011-04-11       Impact factor: 2.447

2.  Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.

Authors:  Penelope Korkolopoulou; Georgia Levidou; Elias A El-Habr; Christos Adamopoulos; Vassilis Samaras; Athanasios Zisakis; Nikolaos Kavantzas; Efstathios Boviatsis; Paraskevi Fragkou; Athanasios G Papavassiliou; Efstratios Patsouris; Christina Piperi
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

3.  Tyrosine kinase ETK/BMX is up-regulated in bladder cancer and predicts poor prognosis in patients with cystectomy.

Authors:  Shengjie Guo; Feng Sun; Zhiyong Guo; Wei Li; Alan Alfano; Hegang Chen; Clara E Magyar; Jiaoti Huang; Toby C Chai; Shaopeng Qiu; Yun Qiu
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

4.  Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma.

Authors:  Wei-Ming Li; Chun-Nung Huang; Yi-Chen Lee; Szu-Han Chen; Hui-Hui Lin; Wen-Jeng Wu; Ching-Chia Li; Hsin-Chih Yeh; Lin-Li Chang; Wei-Chi Hsu; Hung-Lung Ke
Journal:  Int J Med Sci       Date:  2017-10-15       Impact factor: 3.738

Review 5.  STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors.

Authors:  Maciej Golus; Piotr Bugajski; Joanna Chorbińska; Wojciech Krajewski; Artur Lemiński; Jolanta Saczko; Julita Kulbacka; Tomasz Szydełko; Bartosz Małkiewicz
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

6.  Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis,  Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.

Authors:  Georgia Levidou; Sotirios Sachanas; Gerassimos A Pangalis; Christina Kalpadakis; Xanthi Yiakoumis; Maria Moschogiannis; Athanasia Sepsa; Eleftheria Lakiotaki; Vassilis Milionis; Marie-Christine Kyrtsonis; Theodoros P Vassilakopoulos; Pantelis Tsirkinidis; Flora Kontopidou; Styliani Kokoris; Marina Siakantaris; Maria Angelopoulou; Helen Papadaki; Nikolaos Kavantzas; Panayiotis Panayiotidis; Efstratios Patsouris; Penelope Korkolopoulou
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

7.  The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.

Authors:  Anastasios Stofas; Georgia Levidou; Christina Piperi; Christos Adamopoulos; Georgia Dalagiorgou; Aristotelis Bamias; Alexandra Karadimou; George A Lainakis; Stefanos Papadoukakis; Konstantinos Stravodimos; Meletios-Athanasios Dimopoulos; Efstratios Patsouris; Hariklia Gakiopoulou; Penelope Korkolopoulou
Journal:  BMC Cancer       Date:  2014-03-04       Impact factor: 4.430

8.  EGFR may participate in immune evasion through regulation of B7‑H5 expression in non‑small cell lung carcinoma.

Authors:  Zhaohui Dong; Lanying Zhang; Wei Xu; Gensheng Zhang
Journal:  Mol Med Rep       Date:  2018-08-08       Impact factor: 2.952

9.  STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.

Authors:  Sruthi V Hindupur; Sebastian C Schmid; Jana Annika Koch; Ahmed Youssef; Eva-Maria Baur; Dongbiao Wang; Thomas Horn; Julia Slotta-Huspenina; Juergen E Gschwend; Per Sonne Holm; Roman Nawroth
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.